Solarvest BioEnergy Inc SVS.H
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1,470.59
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Solarvest BioEnergy Inc is a Canada based algae biologics company whose production platform provides flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. The company has also initiated a program for the expression of CBD and THC to be produced.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- http://www.solarvest.ca
Valuation
|
Metric
|
SVS.H
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1,470.59 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SVS.H
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.03 |
Interest Coverage | −11.15 |
Quick Ratio
SVS.H
Profitability
|
Metric
|
SVS.H
|
|---|---|
Return on Assets (Normalized) | −209.99% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
SVS.H
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Cwxdrzhhq | Cqggn | $590.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Lgddlqqbn | Lfwrdf | $113.8 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Cqxmgfkw | Tmfqtsj | $108.0 Bil | |
MRNA
| Moderna Inc | Prndnxr | Lqljk | $54.6 Bil | |
BNTX
| BioNTech SE ADR | Jnzjsyrzb | Hqdm | $24.2 Bil | |
ARGX
| argenx SE ADR | Jdhggbjx | Dswz | $21.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ncxxzpj | Mqgdv | $18.8 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Gtmvcptzf | Pstfyhb | $14.3 Bil | |
INCY
| Incyte Corp | Hphnmxsz | Ldccy | $13.0 Bil | |
RPRX
| Royalty Pharma PLC Class A | Xbphhhyb | Txcvxrl | $12.4 Bil |